Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients.
Cumulus has the backing of a successful entrepreneur in the oncology field, and is led by a team of senior professionals, each bringing a wealth of experience across a range of areas including licensing and business development, oncology drug discovery, pre-clinical and clinical development, who have delivered programs leading to the approval and commercial success of new treatments in oncology.
We are keen to hear from organisations who are looking to partner late discovery and clinical stage oncology assets.
Company Details
- Employees
- 19
- Founded
- -
- Address
- George Street, 80,united Kingdom
- cw****@****ogy.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- cumulusoncology.com
- HQ
- Edinburgh, Scotland
Cumulus Oncology Questions
Cumulus Oncology's website is cumulusoncology.com
Cumulus Oncology's LinkedIn profile is https://uk.linkedin.com/company/cumulus-oncology
Cumulus Oncology has
19 employees.
View email and phone details for 19
employees at Cumulus Oncology.
Cumulus Oncology's industry is
Pharmaceutical Manufacturing
Cumulus Oncology's top competitors are
Bioptimus,
Infinitopes,
Adcytherix,
Nodus Oncology,
Quotient Therapeutics,
Draupnir Bio,
Leadxpro Ag,
Gio Therapeutics,
Commit Biologics,
Artica Therapeutics.
Cumulus Oncology's support email address is cwareing@cumulusoncology.com
Cumulus Oncology's categories are Pharmaceutical Manufacturing
Cumulus Oncology's founding year is 2017
